Stockscreener 앱 받기
3.69
6.35%
-0.25
Adagene Inc Adr 주식(ADAG)의 최신 뉴스
Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA - wahanariau.com
Adagene Inc. (NASDAQ: ADAG) insider reports 2.39M shares, 5.1% stake - Stock Titan
Adagene (NASDAQ: ADAG) CSO reports options and warrant stakes - Stock Titan
Adagene (ADAG) CFO Tam Man Kin details shares, RSUs and options - Stock Titan
Adagene Inc. (ADAG) CEO Peter Luo reports options, RSUs and shares in Form 3 - Stock Titan
Adagene (ADAG) HR executive Form 3 details options, RSUs and shares - Stock Titan
Adagene (NASDAQ: ADAG) director details stock option holdings - Stock Titan
Adagene (ADAG) finance leader lists options, RSUs and shares - Stock Titan
Adagene (NASDAQ: ADAG) director details 70,000-share option position in Form 3 - Stock Titan
Adagene (NASDAQ: ADAG) CMO discloses stock options, RSUs and shares - Stock Titan
Adagene Inc. (ADAG) director lists time and performance stock options - Stock Titan
Adagene's Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA - Bitget
Ulf Grawunder Net Worth (2026) - GuruFocus
Adagene (ADAG) to Release Earnings on Monday - MarketBeat
Adagene Spotlights ADG126 at Leerink, Teases New MSS Colorectal Cancer Data Update Soon - MarketBeat
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Short Interest Down 24.5% in February - MarketBeat
Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk - MarketBeat
Comparing KALA BIO (NASDAQ:KALA) and Adagene (NASDAQ:ADAG) - Defense World
Adagene to Participate in Two Upcoming Investor Conferences - The Manila Times
Adagene sets Oppenheimer, Leerink fireside chats for Feb. 25, March 9 - Stock Titan
Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders - TradingView
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 283.2% - Defense World
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 283.2% - MarketBeat
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Drops By 31.1% - MarketBeat
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Adagene (ADAG) and Johnson & Johnson (JNJ) - The Globe and Mail
Adagene Provides Business Update and 2026 Objectives - The Manila Times
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 48.9% - MarketBeat
Total debt per share of Adagene, Inc. Sponsored ADR – LS:A2QN45 - TradingView — Track All Markets
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Declines By 36.8% - MarketBeat
Analysts Set Expectations for Adagene FY2025 Earnings - Defense World
Analysts Issue Forecasts for Adagene FY2025 Earnings - MarketBeat
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug - The Globe and Mail
Adagene, Palvella up after FDA Fast Track tags (ADAG:NASDAQ) - Seeking Alpha
Adagene stock soars after FDA grants Fast Track status for cancer therapy - Investing.com Nigeria
Adagene stock soars after FDA grants Fast Track status for cancer therapy By Investing.com - Investing.com South Africa
FDA grants fast track status to Adagene’s muzastotug for colorectal cancer - Investing.com
FDA grants fast track status to Adagene’s muzastotug for colorectal cancer By Investing.com - Investing.com South Africa
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126) - GlobeNewswire
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives $7.67 Consensus Target Price from Analysts - Defense World
Adagene (NASDAQ:ADAG) Earns Buy Rating from Analysts at Guggenheim - Defense World
Adagene (NASDAQ:ADAG) Now Covered by Guggenheim - MarketBeat
1.20%
0.06%
자본화:
|
볼륨(24시간):